CABOZANTINIB S-MALATE for Metastatic renal cell carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 1,055 adverse event reports in the FDA FAERS database where CABOZANTINIB S-MALATE was used for Metastatic renal cell carcinoma.

Most Reported Side Effects for CABOZANTINIB S-MALATE

Side Effect	Reports	%	Deaths	Hosp.
Diarrhoea	8,282	21.1%	315	1,313
Fatigue	6,819	17.4%	261	897
Off label use	5,245	13.4%	591	633
Nausea	4,341	11.1%	175	736
Decreased appetite	4,076	10.4%	233	751
Blood pressure increased	2,939	7.5%	63	416
Malignant neoplasm progression	2,718	6.9%	909	626
Palmar-plantar erythrodysaesthesia syndrome	2,706	6.9%	119	349
Weight decreased	2,657	6.8%	139	462
Stomatitis	2,560	6.5%	91	347
Death	2,504	6.4%	2,497	368
Constipation	2,098	5.3%	91	359
Blister	1,943	5.0%	27	150
Vomiting	1,870	4.8%	113	491
Taste disorder	1,851	4.7%	43	236